Far Infrared Radiation Treatment for Bipolar Condition
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Bipolar Condition
1 other identifier
interventional
3
1 country
1
Brief Summary
A preliminary study to determine the possibility of using far infrared radiation for the treatment of the Bipolar Condition
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Sep 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 12, 2007
CompletedFirst Posted
Study publicly available on registry
December 14, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedAugust 17, 2009
August 1, 2009
1.4 years
December 12, 2007
August 14, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary end point is to determine the therapeutic effects of far infrared radiation on bipolar condition.
2 years
Secondary Outcomes (1)
The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other related mental illness including Depression, Anxiety, Stress and Insomnia.
2 years
Study Arms (1)
1
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Persons with Bipolar Condition, Depression, Anxiety, Stress and Insomnia
You may not qualify if:
- Persons with severe mental illness that are confined to mental hospitals etc. as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM) are excluded from this clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Centre for Incurable Diseases
Mississauga, Ontario, L5R 3G9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kwasi Donyina, Ph.D.
GAAD Medical Research Institute Inc.
- STUDY DIRECTOR
Ken Nedd, M.D.
GAAD Medical Research Institute Inc.
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 12, 2007
First Posted
December 14, 2007
Study Start
September 1, 2006
Primary Completion
February 1, 2008
Study Completion
June 1, 2008
Last Updated
August 17, 2009
Record last verified: 2009-08